Rate My Professor Warwick Butt

Warwick Butt's research specializations focus on short- and long-term outcomes of paediatric intensive care unit patients and the application of extracorporeal technologies in critical illness, including ECMO, renal replacement therapy, sepsis resuscitation, cardiac surgery recovery, acquired brain injury, lung disease, and quality of life post-discharge. He directs major initiatives such as the RESPOND multicentre randomised controlled trial on vitamin C and hydrocortisone in paediatric septic shock (2022-2026), the NITRIC trial follow-up assessing neurodevelopmental outcomes after nitric oxide in infant heart surgery, the EPICS study on early peritoneal dialysis post-cardiac surgery, oedema quantification in ventilated children with congenital heart disease, protein binding analyses on ECMO circuits, and international collaborations like ASCEND, PROSPECT, and LPCI (Life after Paediatric Critical Illness). Key publications include "Characterization of Protein Binding on an Extracorporeal Membrane Oxygenation (ECMO) Circuit Following the Priming Procedure" (ASAIO Journal, 2025), "Resuscitation in Paediatric Septic Shock Using Vitamin C and Hydrocortisone (RESPOND): The RESPOND Randomized Controlled Trial Protocol" (Pediatric Critical Care Medicine, 2025), "Comprehensive Characterization of Surface-Bound Proteins and Measurement of Fibrin Fiber Thickness on Extracorporeal Membrane Oxygenation Circuits Collected From Patients" (Pediatric Critical Care Medicine, 2024), "A Clinical Score for Quantifying Edema in Mechanically Ventilated Children With Congenital Heart Disease in Intensive Care" (Critical Care Explorations, 2023), and "Shedding light on carboxyhaemoglobin in extracorporeal membrane oxygenation" (Critical Care, 2023). With over 300 scientific communications, he delivers invited lectures at world congresses in general and cardiac critical care, holds editorial board positions on Critical Care Medicine (US) and Critical Care and Resuscitation (Australia), reviews for the European Journal of Intensive Care Medicine, and formerly chaired the Paediatric Study Group of the Australian and New Zealand Intensive Care Society, profoundly influencing the field through enhanced survival rates, reduced complications, and improved long-term recovery for critically ill children.